(Q36662926)

15 August 2017

1 reference

title

Challenges associated with metabolic syndrome (English)

1 reference

15 August 2017

1 reference

Sarah A Spinler

1

1 reference

PubMed ID

17125447

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

26

1 reference

15 August 2017

12 Pt 2

1 reference

15 August 2017

209S-217S

1 reference

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

15 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Secular trends in cardiovascular disease risk factors according to body mass index in US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Trends in waist circumference among U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Increasing prevalence of the metabolic syndrome among u.s. Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

The metabolic syndrome: more than the sum of its parts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12PART2.209S

10.1592/PHCO.26.12PART2.209S

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17125447